Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 5, 2026 | $2.31 | +188.8% | $105.46B | +7.1% | $1.86 |
| Q1 FY26ended Mar 31, 2026 | May 7, 2026 | $2.30 | +63.1% | $99.85B | +6.1% | $2.21 |
| Q4 FY25ended Dec 31, 2025 | — | $2.30 | +76.9% | $105.10B | +8.4% | — |
| Q3 FY25ended Sep 30, 2025 | — | −$3.13 | −4571.4% | $102.24B | +7.8% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.80 | −43.3% | $98.43B | +8.4% | — |
| Q1 FY25ended Mar 31, 2025 | — | $1.41 | +60.2% | $94.07B | +6.9% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.30 | −17.7% | $96.96B | +3.6% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.07 | −96.0% | $94.88B | +6.0% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe CVS Health shares, not any token. As of Aug 5, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $1.41 | — | $90.84B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.88 | — | $87.98B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $1.58 | — | $93.55B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $1.75 | — | $89.49B | — | — |